← Open Payments lookup

IAN SNIDER: Open Payments

NPI 1871174748 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,512 in 156 payments from 16 companies in 2025. Trend: 2023 $2,132 · 2024 $3,472 · 2025 $4,512

Food & beverage: $4,400Education: $111
CompanyPaymentsAmount
Alkermes, Inc.20$754
Neurocrine BioSciences, Inc.25$655
Janssen Pharmaceuticals, Inc21$654
Otsuka America Pharmaceutical, Inc.16$506
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$374
Vanda Pharmaceuticals Inc.10$326
ABBVIE INC.17$316
Axsome Therapeutics, Inc.5$297
Teva Pharmaceuticals USA, Inc.5$157
Supernus Pharmaceuticals, Inc.9$155

Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, REXULTI, CAPLYTA, FANAPT, VRAYLAR, Auvelity.

Industry payments across CA — which companies pay providers there.